Recent News
July 14, 2026
Activate Welcomes 50 New Fellows to Cohort 2026
Two companies based on Columbia technology are part of Activate New York's 2026 cohort: Nanovib is spun out of Dr. Wei Min's lab, and Redox Metals is spun out of Dr. Alan West's lab.
July 06, 2026
Carbontech Development Initiative Announces Fourth and Final Cohort for Research and Commercialization Grants
The Carbontech Development Initiative (CDI) is pleased to announce its final funding awards totaling more than $2.3 million to startups and academic institutions working to develop and scale critical carbon-related technologies.
June 23, 2026
AI Tool Developed at NewYork-Presbyterian and Columbia to Detect Hidden Heart Disease Receives FDA Approval
Developed by Dr. Pierre Elias, EchoNext is the world’s first FDA-approved AI detection tool that analyzes electrocardiograms (ECGs) to detect high-risk structural heart disease.